Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · IEX Real-Time Price · USD
29.19
+0.22 (0.76%)
Jul 2, 2024, 4:00 PM EDT - Market closed
IART Revenue
Integra LifeSciences Holdings had revenue of $1.53B in the twelve months ending March 31, 2024, down -2.07% year-over-year. Revenue in the quarter ending March 31, 2024 was $368.87M, a -3.14% decrease year-over-year. In the year 2023, Integra LifeSciences Holdings had annual revenue of $1.54B, a decrease of -1.03%.
Revenue (ttm)
$1.53B
Revenue Growth
-2.07%
P/S Ratio
1.50
Revenue / Employee
$387,633
Employees
3,946
Market Cap
2.30B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.54B | -16.09M | -1.03% |
Dec 31, 2022 | 1.56B | 15.22M | 0.99% |
Dec 31, 2021 | 1.54B | 170.58M | 12.43% |
Dec 31, 2020 | 1.37B | -145.69M | -9.60% |
Dec 31, 2019 | 1.52B | 45.12M | 3.06% |
Dec 31, 2018 | 1.47B | 284.21M | 23.92% |
Dec 31, 2017 | 1.19B | 196.16M | 19.77% |
Dec 31, 2016 | 992.08M | 109.34M | 12.39% |
Dec 31, 2015 | 882.73M | 86.02M | 10.80% |
Dec 31, 2014 | 796.72M | 99.89M | 14.33% |
Dec 31, 2013 | 696.83M | -134.04M | -16.13% |
Dec 31, 2012 | 830.87M | 50.79M | 6.51% |
Dec 31, 2011 | 780.08M | 48.01M | 6.56% |
Dec 31, 2010 | 732.07M | 49.58M | 7.26% |
Dec 31, 2009 | 682.49M | 27.88M | 4.26% |
Dec 31, 2008 | 654.60M | 104.15M | 18.92% |
Dec 31, 2007 | 550.46M | 131.16M | 31.28% |
Dec 31, 2006 | 419.30M | 141.36M | 50.86% |
Dec 31, 2005 | 277.94M | 48.11M | 20.93% |
Dec 31, 2004 | 229.83M | 44.23M | 23.83% |
Dec 31, 2003 | 185.60M | 67.78M | 57.52% |
Dec 31, 2002 | 117.82M | 24.38M | 26.09% |
Dec 31, 2001 | 93.44M | 21.79M | 30.42% |
Dec 31, 2000 | 71.65M | 28.77M | 67.11% |
Dec 31, 1999 | 42.88M | 25.32M | 144.15% |
Dec 31, 1998 | 17.56M | 2.82M | 19.09% |
Dec 31, 1997 | 14.75M | 1.60M | 12.15% |
Dec 31, 1996 | 13.15M | 2.92M | 28.54% |
Dec 31, 1995 | 10.23M | 1.57M | 18.10% |
Dec 31, 1994 | 8.66M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch Health Companies | 8.97B |
PTC Therapeutics | 927.56M |
Tandem Diabetes Care | 770.01M |
10x Genomics | 625.45M |
STAAR Surgical Company | 326.24M |
Rhythm Pharmaceuticals | 91.93M |
Agios Pharmaceuticals | 29.40M |
Celldex Therapeutics | 6.07M |
IART News
- 7 weeks ago - Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference - GlobeNewsWire
- 2 months ago - Integra LifeSciences Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting - GlobeNewsWire
- 2 months ago - Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024 - GlobeNewsWire
- 3 months ago - Integra LifeSciences Completes the Acquisition of Acclarent, Inc. - GlobeNewsWire
- 3 months ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART - PRNewsWire
- 4 months ago - Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases - GlobeNewsWire
- 4 months ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March - Ironwood Pharmaceuticals (NASDAQ:IRWD), Integra Lifesciences (NASDAQ:IART) - Benzinga